Today: 19 May 2026
Browse Category

NASDAQ:CAN 22 September 2025 - 19 May 2026

Bitcoin Price Today: BTC Nears $76,000 Test as ETF Demand Rebounds, Miner Selling Caps Rally

Bitcoin Price Today: BTC Nears $76,000 Test as ETF Demand Rebounds, Miner Selling Caps Rally

Bitcoin traded near $74,400 early Tuesday after hitting a four-week high, buoyed by $1 billion in new purchases from Strategy and strong inflows into U.S. spot bitcoin ETFs last week. Farside data showed the ETF group swung to a $291 million net outflow Monday, with BlackRock’s IBIT gaining but Fidelity’s FBTC and Ark’s ARKB losing funds. Miners including MARA and Riot sold thousands of bitcoin in recent weeks.
14 April 2026
···
Canaan Inc (CAN) Stock: BTIG Buy Rating, Green Bitcoin Pivot and 2026 Forecasts — December 8, 2025

Canaan Inc (CAN) Stock: BTIG Buy Rating, Green Bitcoin Pivot and 2026 Forecasts — December 8, 2025

BTIG initiated coverage of Canaan Inc. (NASDAQ: CAN) with a Buy rating and a $3.00 price target on December 8, 2025, implying over 220% upside from its latest close of $0.93. The stock is up 32% in three months but remains down 69% over the past year. Canaan’s Q3 2025 revenue doubled year-over-year to $150.5 million, with losses narrowing. Average daily trading volume stands near 17 million shares.
8 December 2025
·
Canaan (NASDAQ: CAN) Soars Over 20% as Q3 2025 Revenue Doubles and Bitcoin Mining Expansion Accelerates

Canaan (NASDAQ: CAN) Soars Over 20% as Q3 2025 Revenue Doubles and Bitcoin Mining Expansion Accelerates

Canaan Inc. shares jumped 22% to $1.03 by midday Wednesday after Q3 2025 revenue more than doubled to $150.5 million, beating estimates. Product sales hit $118.6 million and mining revenue reached a record $30.6 million. Gross profit swung to $16.6 million from a loss last year, though the company posted a net loss of $27.7 million. Market value rose to about $475 million.
19 November 2025
···
Bitcoin vs Ethereum 2025: The Ultimate Crypto Investment Showdown 🚀💰

Bitcoin vs Ethereum 2025: The Ultimate Crypto Investment Showdown 🚀💰

Bitcoin reached a record high near $117,000 in 2025 after the April 2024 halving, while Ethereum rallied to around $4,500 following sharp volatility. The two assets now account for about 70% of the crypto market’s value. U.S. spot Bitcoin and Ethereum ETFs, launched in 2024, drew billions in inflows by 2025. Bitcoin’s rise has been steadier, while Ethereum saw sharper swings.
22 September 2025
········

Stock Market Today

  • Yacktman Asset Management Cuts Alphabet Inc. Stake Amid Mixed Institutional Moves
    May 19, 2026, 2:13 PM EDT. Yacktman Asset Management LP reduced its stake in Alphabet Inc. (NASDAQ:GOOG) by 3.1% in Q4, selling 36,606 shares and holding 1,129,807 shares valued at $354.5 million, representing 5% of its portfolio. Other institutional investors showed varied activity with Brighton Jones LLC and Worldquant Millennium Advisors LLC increasing their holdings significantly. Alphabet's stock saw multiple analyst ratings, including 'outperform' and 'buy' with target prices ranging from $345 to $450, reflecting positive sentiment from firms like Scotiabank, TD Cowen, and Deutsche Bank. Institutional investors own 27.26% of Alphabet's shares. The stock remains a top focus amid ongoing trading by hedge funds and asset managers.

Latest articles

Astera Labs Moves Higher as Wall Street Eyes Next AI Bottleneck

Astera Labs Moves Higher as Wall Street Eyes Next AI Bottleneck

19 May 2026
Astera Labs shares surged 15.2% to $248.36 Tuesday after Evercore ISI raised its price target and management highlighted rising AI data-center demand. CEO Jitendra Mohan said revenue grew from $65 million at its 2024 IPO to $308 million last quarter. The company’s market value neared $45 billion, with shares trading at about 168 times earnings. One customer accounted for over 70% of projected 2025 revenue.
Recursion Stock Slumps to 52-Week Low as Traders Eye FDA News

Recursion Stock Slumps to 52-Week Low as Traders Eye FDA News

19 May 2026
Recursion Pharmaceuticals shares fell 2.2% to $2.825 Tuesday, hitting a 52-week low of $2.77, after reporting first-quarter revenue of $6.47 million, down from $14.75 million a year earlier. Net loss narrowed to $117.5 million. Early clinical data for REC-1245 showed no dose-limiting toxicities in 16 solid-tumor patients. The company ended March with $665.2 million in cash.
Wall Street’s Top Picks for U.S. Stocks as Yields Stay High

Wall Street’s Top Picks for U.S. Stocks as Yields Stay High

19 May 2026
U.S. stocks fell Tuesday as the 10-year Treasury yield reached its highest point since January 2025, pressuring growth shares. Nvidia drew the most attention ahead of its earnings, with options markets pricing in a possible $355 billion swing in value. Dell highlighted new AI infrastructure partnerships, while ServiceNow received a fresh Buy rating from Bank of America.
Go toTop